CellChorus
Andrew J. Last has extensive experience in leadership roles across the biotechnology and life sciences sectors. Currently a member of the Board of Directors at CellChorus and OncoCyte, Andrew has previously served as Chief Operating Officer for Bio-Rad Laboratories, overseeing global business operations, and Chief Commercial Officer for Berkeley Lights, where innovative commercial strategies were implemented. Andrew's background also includes executive positions at Intrexon Corporation, Affymetrix, BD Biosciences, Applied Biosystems, Incyte Genomics, and Monsanto Company, contributing to advancements in genomic technologies and diagnostics. Andrew holds a PhD in Agrochemicals, an MSc in Bio-Aeronautics, and a BSc in Biological Sciences from respected institutions including Cranfield University and the University of Leicester.
This person is not in the org chart
This person is not in any teams
CellChorus
CellChorus® is a high-throughput platform for evaluating how individual cells move, behave and interact. The company applies visual AI to evaluate Time-lapse Imaging Microscopy in Nanowell Grids (TIMING™) videos and characterize cell behavior such as movement, activation, killing, and survival.